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496 The Journal of Thoracic and CardioObjective: We sought to compare the 6-month angiographic patency rates of greater
saphenous veins removed during coronary artery bypass grafting with the endo-
scopic vein harvest or open vein harvest techniques.
Methods: Two hundred patients undergoing nonemergency on-pump coronary ar-
tery bypass grafting were prospectively randomized to either endoscopic vein
harvest or open vein harvest. Follow-up angiography of all vein grafts was sched-
uled at 6 months. Graft patency and disease grades were assigned independently by
2 interventional cardiologists. Leg wound healing was evaluated at discharge, 1
month, and 6 months for evidence of complications.
Results: There were 3 conversions from endoscopic vein harvest to open vein
harvest because of vein factors. Leg wound complications were significantly lower
in the endoscopic vein harvest group (7.4% vs 19.4%, P  .014). On multivariable
analysis, endoscopic vein harvest emerged as the only factor affecting wound
complications (odds ratio, 0.33). Three deaths (2 perioperative and 1 late) occurred
in the endoscopic vein harvest group that were unrelated to vein graft closure.
Twenty-four and 29 patients in the endoscopic vein harvest and open vein harvest
cohorts, respectively, refused the follow-up 6-month angiography. Therefore a total
of 144 angiograms (73 endoscopic vein harvests and 71 open vein harvests) and 336
vein grafts (166 endoscopic vein harvests and 170 open vein harvests) were
available for analysis. The overall occlusion rates at 6 months were 21.7% for
endoscopic vein harvest and 17.6% for open vein harvest. Additionally, there was
evidence of significant disease (50% stenosis) in 10.2% and 12.4% of endoscopic
vein harvest and open vein harvest grafts, respectively. By means of ordinal
hierarchic logistic regression, endoscopic vein harvest was not found to be a risk
factor for vein graft occlusion or disease (odds ratio, 1.15). Significant predictors
were congestive heart failure (odds ratio, 2.87), graft to the diagonal artery territory
(odds ratio, 1.76), larger vein conduit size (odds ratio, 1.32), and graft flow (odds
ratio, 0.90).
Conclusion: Endoscopic vein harvest reduces leg wound complications compared
with open vein harvest without compromising the 6-month patency rate. The overall
patency rate depends on target and vein-related variables and patient characteristics
rather than the method of vein harvesting.
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CDEndoscopic vein harvest (EVH) for coronarybypass grafting (CABG) has been demon-strated to decrease the incidence of legwound infection and complications1-6 com-pared with the traditional open vein harvest(OVH) technique. However, there continue
to be concerns that scope manipulation of the vein might
cause trauma to the vessel, which might lead to early
stenosis or occlusion. In this regard, EVH has not been
shown to compromise the histologic integrity7-9 or func-
tional properties10-12 of the endothelial, medial, and adven-
titial layers. Moreover, the short-term 6-month patency rate
of EVH veins, as assessed by means of contrast-enhanced
electron beam computed tomography,13 compares favorably
with those historically reported for OVH veins. In a small
randomized trial of 35 patients at the University of
Montreal,14 the angiographic 3-month patency rates were
similar between the EVH and OVH groups. However, no
differences in wound infection rates were observed. In this
study we compared the 6-month patency and stenosis rates
of vein grafts by using follow-up angiography in patients
randomized to either EVH or OVH techniques of saphenous
vein harvesting. Multivariable analytic methods were used
to determine risk factors for vein graft occlusion and dis-
ease, as well as leg wound complications.
Methods
Protocol
Between November 2000 and October 2002, 236 nonconsecutive
patients undergoing isolated CABG at Southern California Kaiser
Permanente Medical Center in Los Angeles agreed to be prospec-
tively randomized to either endoscopic or open vein harvesting.
Exclusion criteria included less than 2 planned vein graft CABGs,
emergency operations, history of greater saphenous vein stripping,
and redo CABG with previously harvested greater saphenous vein.
Those patients deemed not to be EVH candidates because of
insufficient subcutaneous tissue to allow insertion of the endo-
scopic instruments were also excluded. Of the 236 patients, 21
withdrew voluntarily from the study before the operation. Because
of the nonbypassable nature of poor targets during the initial
assessment on sternotomy, another 15 patients were excluded from
randomization because only one vein graft was required. Standard
moderate hypothermia (32°C) cardiopulmonary bypass was used
in all participants. Beating-heart surgery was not performed to
avoid introducing technical factors that might compromise graft
patency. All saphenous vein bypasses were fashioned as single
grafts with direct proximal aortic anastomoses. Because of rela-
tively less experience with the EVH technique in the lower leg,
only greater saphenous veins from one or both thighs were har-
vested for the purpose of this study. In most cases a sufficient
quantity of vein conduits was obtained from one thigh only.
Intraoperatively, the severity of each target vessel disease (A,
minimal disease; B, presence of significant atherosclerotic changes;
C, severe calcified disease) was recorded. The caliber of the
coronary artery was assessed by means of gentle single passes with
smooth probes for a short distance to minimize any potential
The Journal of Thoraciendothelial injury. The internal diameter of each vein conduit was
also measured directly with varying sized probes, and the number
of repairs with fine polypropylene sutures was noted. The presence
of significant varicosity or phlebitic changes was also documented.
Before sternal closure, vein graft flow rates were obtained by using
appropriately sized Doppler flow probes (Transonic Systems, Inc,
Ithaca, NY).
Glucose levels were maintained at less than 150 mg/dL both
intraoperatively and postoperatively according to a strict protocol.
All patients were treated with aspirin and statin drug therapy
beginning on the first postoperative day. The study was approved
by our institution’s investigational review board.
Leg Wound Complications
Leg wound healing was evaluated at discharge, at 1 month, and at
the 6-month follow-up coronary angiography session. Patients who
subsequently refused to have postoperative angiography were as-
sessed by means of chart review, follow-up with the referring
cardiologist, and direct telephone contact. Wound complications
were defined as drainage (serous, purulent, or sanguinous), seroma
or hematoma formation, positive wound culture for bacterial in-
fection, cellulitis requiring antibiotic treatment, hospital readmis-
sion, or documented additional clinic or home health nurse visit for
wound care.
Six-month Patency Rates
Follow-up angiography of all vein grafts was scheduled at 6
months after the operation by using the standard percutaneous
transfemoral technique. The grafts were selectively catheterized
and visualized in 4 projections. A bolus of contrast was injected in
the ascending aorta to confirm graft occlusions. All angiograms
were reviewed independently by 2 interventional cardiologists
who were blinded to the vein-harvesting technique. Graft patency
was assigned as patent with unimpaired runoff, patent but with
disease producing greater than 50% stenosis of the graft, or oc-
cluded. When there was a difference of opinion on patency and
disease, the worst-case scenario was used in the analysis. The 2
cardiologists were in agreement 97% of the time.
Surgical Techniques
All patients’ legs were circumferentially prepped with povidone
iodine solution, and the feet were placed in sterile stockinettes.
Before vein harvesting, 5000 units of intravenous heparin was
administered. EVH was performed with the Vaso-View system
(Guidant Corporation, Menlo Park, Calif), which uses CO2 insuf-
flation for visualization and dissection. One of 3 physician’s as-
sistants, each with approximately 300 EVH case experiences,
performed the procedure in every operation. Briefly, a 1.5- to
2.0-cm incision was made medially above or below the knee,
depending on the length of vein required. Harvesting was directed
toward the groin region for as far proximally as possible. Side
branches were divided by using bipolar cauterizing scissors or a
bisector. A small puncture was made under endoscopic guidance
proximally over the saphenous vein, which was then clamped and
divided, and the proximal end was ligated. After removing the vein
from the leg, side branches were ligated with 4° silk ties. The
incisions were closed with absorbable subcutaneous and subcutic-
ular sutures and then wrapped with an elastic Ace bandage.
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CDIn the OVH group a longitudinal incision was made over the
course of the saphenous vein starting at the groin region, with the
length of incision dependent on the amount of vein required for the
operation. Once exposed, side branches were divided between 4°
silk ties. The wound was closed in layers by using absorbable
sutures and again wrapped with an Ace bandage.
All veins were gently distended manually with autologous
heparinized blood. Any avulsed branches were either repaired by
carefully approximating the adventitial layer with 7° polypro-
pylene sutures or excluded if fortuitously located between vein
graft segments. The veins were then placed in a heparinized blood
solution containing papavarine until ready for use.
Statistical Analysis
Continuous data are expressed as the mean  SD unless specified
otherwise. Demographic characteristics and intraoperative vari-
ables of each surgical group were compared by using a contin-
TABLE 1. Preoperative patient characteristics according
to vein harvest method (intention to treat)
EVH
(n  100)
OVH
(n  100) P value
Age (y) 64 9 64  9 .82
Sex (female) 7% 7% 1.00
Smoking 70% 64% .37
Hypertension 76% 74% .75
Myocardial infarction 48% 44% .57
Congestive heart failure 13% 14% .82
Diabetes mellitus 36% 35% .93
Peripheral vascular disease 9% 8% .84
Carotid disease 5% 11% .11
Stroke 6% 6% 1.00
NYHA class .51
I 66% 64%
II 20% 26%
III 13% 8%
IV 1% 2%
Values are presented as means  1 SD. EVH, Endoscopic vein harvest;
OVH, open vein harvest; NYHA, New York Heart Association.
TABLE 2. Wound complications according to vein harvest
method
EVH
(n  7)
OVH
(n  20)
Drainage
Purulent 2 6
Serous 1 2
Sanguinous 0 0
Hematoma 2 3
Seroma 0 1
Open wound 1 3
Cellulitis 1 13
EVH, Endoscopic vein harvest; OVH, open vein harvest.gency table for categoric variables and analysis of variance for
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entered into a conventional multivariable logistic regression to
determine the predictors of leg wound complications: vein harvest
method, age, sex, hypertension, history of myocardial infarction,
congestive heart failure, diabetes mellitus, peripheral vascular dis-
ease, cerebrovascular disease, previous stroke, and tobacco use. In
addition, the following target vessel and vein variables, along with
the above factors, were entered into an ordinal heirarchic logistic
regression (with robust variance estimators to accommodate the
lack of statistical independence caused by clustering of grafts
within patients) to determine the predictors of graft occlusion and
disease: severity of target vessel disease, size of target vessel,
territory of target vessel (right, left anterior descending, and cir-
cumflex coronary artery systems), vein conduit size, vein quality,
graft flow, and vein graft repair. The outcomes in the regression
were ordered as patent, patent but significantly diseased, and
occluded. Results are presented by using odds ratios (ORs) with
95% confidence intervals (CIs).
Results
Patients undergoing EVH and OVH had very similar clin-
ical profiles (Table 1). Carotid stenosis was more prevalent
in the OVH group (11% vs 5%), but this did not achieve
statistical significance. Most patients were in New York
Heart Association classes I and II with hypertension and
smoking history.
There were 2 perioperative deaths, both in the EVH
group. One patient died on postoperative day 13 as a result
of complications of stroke, and the other died on postoper-
ative day 12 as a result of respiratory failure and sepsis.
These 2 patients were excluded from the leg wound com-
plication analysis. One patient in the EVH cohort died of
esophageal carcinoma 6 weeks after the operation.
There were 3 conversions from EVH to OVH. The vein
was too superficial to allow insertion of the endoscopic
TABLE 3. Conventional logistic regression for leg wound
infection
Risk factor
Odds ratio
(95% confidence interval)
Age 0.99 (0.95-1.04)
Sex (female) 1.82 (0.47-7.00)
Hypertension 0.77 (0.32-1.90)
Myocardial infarction 0.78 (0.34-1.78)
Congestive heart failure 1.23 (0.39-3.92)
Diabetes mellitus 0.47 (0.18-1.23)
Carotid disease 0.40 (0.05-3.14)
Stroke 0.56 (0.07-4.52)
Peripheral vascular disease 0.82 (0.18-3.81)
Smoking 0.83 (0.36-1.92)
EVH (vs OVH) 0.33 (0.13-0.82)
Two early perioperative deaths were excluded. EVH, Endoscopic vein
harvest; OVH, open vein harvest.dissecting instrument in 2 cases and deemed to be too small
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CDto allow safe endoscopic harvesting in the third. Although
the intent-to-treat was EVH, these patients were counted in
the OVH group from the leg wound standpoint because of
the fact that the actual method of vein harvest required a
conventional longitudinal open incision.
Wound complications occurred in 7.4% (7/95) of pa-
tients having EVH versus 19.4% (20/103) of those having
the traditional OVH technique (P  .014). The types of
wound complications in each group are shown in the Table
2. Most of the wound complications in the EVH cohort
resolved with outpatient oral antibiotics. One patient re-
quired wound debridement and packing. On the other hand,
there were more cases of periwound cellulitis and purulent
discharge with 3 open wounds in the OVH group. On
multivariable logistic regression (Table 3), EVH (OR, 0.33;
95% CI, 0.13-0.82; P  .017) was found to be the only
factor (protective vs OVH) affecting wound complications.
Twenty-four and 29 patients in the EVH and OVH
groups, respectively, refused the follow-up 6-month vein
graft angiography. Therefore a total of 144 angiograms (73
TABLE 4. Coronary artery size and disease, vein conduit
diameter and quality, and graft flow according to vein
harvest method
EVH
(n  166)
OVH
(n  170)
Coronary artery size (mm) 1.4 0.3 1.4 0.2
Coronary artery disease grade
A 60 (36%) 70 (41%)
B 78 (47%) 67 (39%)
C 28 (17%) 33 (19%)
Vein graft internal diameter (mm) 4.0 0.9 3.9 0.9
Vein graft grade
A 133 (80%) 138 (81%)
B 33 (20%) 32 (19%)
Graft flow (mL/min) 91 47 91 46
Values are presented as means SD. EVH, Endoscopic vein harvest; OVH,
open vein harvest. Coronary artery disease grade: A, minimal disease; B,
atherosclerotic disease; C, severely calcified disease. Vein graft grade: A,
good quality conduit; B, presence of significant varicosity or phlebitic
changes.
TABLE 5. Graft patency and disease according to vein
harvest method
EVH
(n  166)
OVH
(n  170)
Patent 113 (68%) 119 (70%)
Significant disease 17 (10%) 21 (12%)
Occlusion 36 (22%) 30 (18%)
P  .584. EVH, Endoscopic vein harvest; OVH, open vein harvest.EVH and 71 OVH) and 336 vein grafts (166 EVH and 170
The Journal of ThoraciOVH) were available for analysis. Because none of the 3
patients who had conversion from EVH to OVH underwent
cardiac catheterization at 6 months, the analyses based on
intent-to-treat or actual treatment were the same.
There were more total vein repairs in the EVH group (28
vs 5) involving 24 grafts in 18 patients. The number of vein
grafts per patient was similar between the 2 cohorts (2.27
[EVH] vs 2.39 [OVH]). In both groups the distribution of
the target vessels was approximately 40% each in the cir-
cumflex and right coronary system. About 20% of vein
grafts were placed to diagonal arteries. Ninety-nine percent
of patients had the left anterior descending artery grafted
with the left internal thoracic artery. As shown in Table 4,
no significant differences were detected in the severity of
target disease and size, vein graft size and quality, and graft
flow rates between the 2 groups.
One patient with OVH had recurrent angina at 2 months,
requiring percutaneous catheter stenting of a stenosed ob-
tuse marginal vein graft, which subsequently occluded on
repeat angiography at 4 months. The overall occlusion rates
after 6 months were 21.7% for EVH and 17.6% for OVH
(Table 5). However, there was evidence of significant dis-
ease (50% stenosis) in an additional 10.2% of EVH grafts
and 12.4% of OVH grafts. There were no differences in the
6-month occlusion and disease rates between EVH and
TABLE 6. Graft patency and disease according to territory
of revascularization
Diagonal
Circumflex, PLCX,
Ramus, and OM
RCA, PLRCA,
and PDA
Patent 40 (59%) 96 (70%) 96 (74%)
Significant
disease
10 (15%) 13 (9%) 15 (11%)
Occlusion 18 (26%) 29 (21%) 19 (15%)
Total 68 (100%) 138 (100%) 130 (100%)
P  .197. PLCX, Posterolateral circumflex artery; OM, obtuse marginal
artery; RCA, right coronary artery; PLRCA, posterolateral right coronary
artery; PDA, posterior descending artery.
TABLE 7. Multivariable ordinal hierarchic logistic regres-
sion for vein graft occlusion and disease
Risk factor
Odds ratio
(95% CI) P value
Vein graft size 1.32 (0.99-1.77) .061
Congestive heart failure 2.87 (1.34-6.17) .007
Vein graft flow 0.90 (0.85-0.97) .003
Diagonal territory 1.76 (1.06-2.95) .030
EVH vs OVH 1.15 (0.65-2.05) .632
CI, Confidence interval; EVH, endoscopic vein harvest; OVH, open vein
harvest.OVH, as determined by means of univariate analysis (P 
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cohorts is tabulated in Table 6. By means of multivariable
logistic regression, EVH was not found to be a significant
risk factor for graft occlusion or disease. The adjusted OR
was 1.15 (95% CI, 0.65-2.05; P .594). As shown in Table 7,
significant predictors for vein graft occlusion and disease
were congestive heart failure (OR, 2.87; 95% CI, 1.34-
6.17), vein graft to the diagonal territory (OR, 1.76; 95% CI,
0.85-0.97), and larger vein graft size (OR, 1.32; 95% CI,
0.99-1.77). Conversely, higher vein graft flow had a protec-
tive effect (OR, 0.90; 95% CI, 0.85-0.97).
Discussion
Despite the increasing use of arterial grafts for CABG
because of more favorable long-term patency, the greater
saphenous vein continues to be the most commonly used
conduit in multivessel bypass operations. However, the
traditional method of vein harvesting with an open longitu-
dinal incision along the course of the greater saphenous vein
has been associated with significant complications, includ-
ing dehiscence, cellulitis, lymphangitis, drainage, edema,
pain, hematomas, skin necrosis, and infection. These, in
turn, lead to delayed wound healing, increased length of
hospital stay, higher cost of postoperative care, and greater
patient discomfort. Leg wound complications from OVH
have been reported to be as high as 24.3% in a large series
of 1047 patients undergoing CABG at the Spartanburg
Regional Medical Center in South Carolina.15 Given the
current trend toward less invasive cardiothoracic surgery,
minimally invasive methods of vein harvesting have been
developed and refined in an attempt to reduce the morbidity
associated with OVH. However, endothelial dysfunction
has been reported with traction injury during minimally
invasive vein harvesting with bridged incisions.16 Because
of concerns of similar possible forces causing vein trauma
during EVH that might lead to early occlusion, we com-
pared the angiographic 6-month patency and significant
stenosis rates of vein grafts harvested by using open versus
endoscopic techniques in a prospective randomized trial.
In this study leg wound–related complications were sig-
nificantly reduced with EVH (7.4% vs 19.4%), which is
consistent with previous reports.1-6 Furthermore, most of
the complications within the EVH group were relatively
minor compared with those in the OVH cohort. By means of
multivariable analysis, EVH was found to be the only sig-
nificant predictor of leg wound complications, with a rela-
tive risk reduction of 67% (OR, 0.33). This is in concor-
dance with findings of other investigators.2,5,6 In a meta-
analysis of 14 randomized trials comparing minimally
invasive vein harvest techniques with the conventional open
technique with regard to leg wound infection, Athanasiou
and associates17 reported a significantly lower rate in the
minimally invasive vein harvest group (OR, 0.22; 95% CI,
500 The Journal of Thoracic and Cardiovascular Surgery ● Mar0.14-0.34). In a subgroup analysis of the minimally invasive
cohort with EVH, the OR of leg wound infections versus
OVH was almost identical to that of the minimally invasive
group as a whole. Surprisingly, diabetes did not emerge as
a significant risk factor in this study. The fact that only thigh
veins were harvested might have reduced the number of
wound complications because diabetic vasculopathy is
largely a small-vessel disease affecting wound healing more
below the knees.
In the present trial the overall 6-month vein graft occlu-
sion rate was 20%, with an additional 11.5% demonstrating
stenotic regions of greater than 50%. No significant patency
differences were noted between EVH and OVH veins.
These figures are similar to those reported by Perrault and
coworkers14 in a smaller prospective randomized trial dur-
ing the same time period. In that study the occlusion rates at
3 months were slightly lower at 14.8% and 15.6% in the
OVH and EVH groups, respectively. However, only 59 vein
grafts were examined versus 336 in this study. This might
be an insufficient sample size because no differences in
wound complications were ascertained. Furthermore, occlu-
sion data from angiography at 3 months might not be
representative of that obtained at 6 months. This is sup-
ported by the fact that an additional 35.5% of grafts showed
the presence of greater than 25% stenosis.
The reported 1-year vein graft occlusion rate with the
OVH technique ranges from approximately 5% to 30%,18-23
with multiple determining factors. In the most contempo-
rary comprehensive series from the National Defence Med-
ical Centre and University of Ottawa Heart Institute,21 the
angiographic vein graft occlusion rate was 12% early and
19% (of 3706 grafts examined) at 1 year. Of the patent
grafts, an additional 6% (5% of all grafts) had significant
stenosis, reducing the caliber of the graft to less than 50% of
the grafted coronary artery. This is consistent with our
finding of a 20% occlusion rate at 6 months. Nevertheless,
these figures were rather disappointing and might reflect the
results of bypassing smaller vessels with more distal disease
because of the advent of aggressive multivessel stenting.
This is supported by the fact that the number of percutane-
ous catheter-based interventions during the study period at
our institution increased by 22% per year, whereas isolated
CABG decreased by 15% per year.
In this study multivariable ordinal hierarchic logistic
regression was used to model not only the variation at both
the patient and graft level but also the outcome of multiple
categories. By means of this analysis, significant predictors
of vein graft occlusion and disease were congestive heart
failure, grafting to diagonal arteries, larger vein graft size,
and lower graft flow. In agreement with other
reports,18,22,24,25 traditional cardiovascular risk factors, such
as hypertension, sex, diabetes mellitus, and previous myo-
cardial infarction, did not affect graft patency and disease.
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farcted myocardium with poor distal runoff. Concordantly,
Shah and colleagues24 found that ejection fraction signifi-
cantly reduced vein graft patency in 1402 symptomatic
patients operated on between 1977 and 1999 at the Austin
Hospital in Melbourne, Victoria, Australia. Similar to other
studies,18,22 higher graft flows conferred a protective effect
against graft occlusion and might reflect a combination of
larger target diameter, less distal coronary disease, and
greater number of runoff branches. This is supported by the
fact that the severity of target disease becomes a significant
predictor for graft occlusion, with an OR of 1.9 if flow is
eliminated from the multivariable analysis. Independently,
patency is inversely related to vein conduit diameter, as
published previously.24 The reason for this is not clear but
might be related to lower velocity flow and greater graft-
to-target mismatch with larger and thicker vein grafts. Be-
cause there is a preferential harvesting of thigh veins over
calf veins with EVH because of its relatively greater ease,
this might be one of the drawbacks of the technique.
Whether target territory is an important determinant of
vein graft patency is controversial. Although Shah and
coworkers24 reported vein graft bypasses to the diagonal
artery had the best long-term patency after those to the left
anterior descending artery, Bjork and associates18 did not
find differences in the early or 1-year patency of vein grafts
to the various territories being revascularized. In this study
grafting of the diagonal artery was associated with higher
occlusion and disease development at 6 months. The reason
for these different findings is unclear. However, diagonal
artery targets are usually smaller and supply a smaller area
of myocardium compared with other vessels in the circum-
flex and right coronary systems.
There are several limitations to the study that should be
addressed. First, because the current method of EVH re-
quires dissection close to the adventitial layer, the surround-
ing tissue was removed in both groups. The preservation of
this fatty pedicle might be important as a natural external
support, thereby protecting the vein against the effects of
aortic shear stress,26 and has been associated with improved
graft patency at 18 months.22 Whether EVH techniques
need to be modified to incorporate this no-touch component
remains to be defined by future prospective randomized
studies.
Second, the list of potential factors contributing to vein
graft occlusion or disease was far from exhaustive because
our focus was on the most relevant clinical variables. Ad-
ditionally, several risk factors, such as renal insufficiency
and chronic obstructive pulmonary disease, were not in-
cluded in the analysis because of the small number of
patients possessing these characteristics.
Third, the results of EVH in this study are based on more
than 300 case experiences for each physician’s assistant and
The Journal of Thoracimight not reflect that during the learning phase of this
technique. Therefore generalization of the findings to other
institutions might not be applicable.
Finally, despite the fact that this is the largest prospective
randomized angiographic trial comparing EVH with OVH,
the sample size might not be adequate because of incom-
plete angiographic follow-up to detect differences in the
patency rates between the 2 methods of vein harvesting.
However, an OR of 1.15 (closed to unity) with a relatively
small 95% CI supports the reliability of the results.
In summary, EVH reduces the leg wound complications
associated with the traditional open harvesting technique
without compromising vein graft patency. The overall pa-
tency rate depends on target and vein-related variables and
patient characteristics rather than the method of vein har-
vesting.
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Discussion
Dr James Fann (Stanford, Calif). The use of EVH has become
more prevalent, mainly as a result of reports of decreased wound
infections and improved wound healing, with consequent financial
implications. As you point out, one is always concerned about the
trauma to the vein from this procedure. Notwithstanding histologic
reports, patency rates on the basis of follow-up coronary angiog-
raphy are what we as surgeons have always wanted to process and
consider to be the gold standard. Therefore, I congratulate you and
your colleagues on this intriguing prospective randomized trial
with 6-month patency data of those undergoing EVH versus OVH.
I have some specific questions the data presented. In the ex-
clusion criteria, what would you consider to be insufficient sub-
cutaneous tissue to allow for insertion of endoscopic instruments,
especially because thigh veins were preferentially used in your
report, and how do you evaluate these patients preoperatively? I
ask this because there were 3 conversions from endoscopic tech-
502 The Journal of Thoracic and Cardiovascular Surgery ● Marnique to that of the open or conventional approach as a result of
overly superficial location of the vein.
Also, I worry about vein repairs in terms of patency, and it must
be emphasized that the number of vein repairs in the endoscopic
group is substantially higher than that in the open group.
As much as we hate to admit it, early graft occlusion occurs,
and on thee basis of this and other recent studies, it appears to
happen more often than we wish. I think this finding is another
important piece of information from your study. Given that the
patency rate in the endoscopic group appeared worse, do you think
the difference in the occlusion rates at 6 months reflects a  error,
and had there been more patients, would the endoscopic approach
have been statistically worse?
Finally, what was the outcome of patients who had graft ste-
nosis or occlusions? Were these patients readmitted to the hospi-
tal? Did they sustain myocardial infarctions?
Again, this article answers some highly relevant issues in
coronary artery surgery, and I thank the Association for the op-
portunity to discuss it.
Dr Yun. Thank you, Dr Fann, for your kind comments and
insightful critique.
To answer your first question, there are some rare patients who
have basically no subcutaneous tissue between the vein and the
dermis layer of the skin. This makes the vein relatively adherent,
and we do not try to introduce the endoscopic instruments in these
patients. Having said that, it takes very little subcutaneous tissue to
dissect the veins with the nose cone of the endoscope. Our phy-
sician’s assistants are now very efficient at harvesting the vein
from the lower leg, meaning the calf. However, we usually do not
know whether there is adequate subcutaneous tissue until the skin
incision is made and the vein is isolated. Because we randomized
patients before skin incision in this study, there were 2 patients
who had their legs opened and were considered conversions,
although the endoscopic instruments were never opened. Preoper-
atively, it is rare in this subset of patients to have the vein visible
around the knee, which tells us that the vein is superficial, but these
are the only patients who were excluded preoperatively on the
basis of this criterion.
Regarding the vein repairs, it is always a concern. Although there
were more total vein repairs in the endoscopic vein-harvesting group,
28 versus 5, this was still only 1 repair for every 8 graft segments.
Most of these were avulsions of small adventitial branches and
were eliminated whenever possible.
In terms of graft patency, the study was originally designed to
have a statistical power of 80% at an  level of .05 to detect a
difference as small as 5% between the 2 groups in either direction.
Unfortunately, we were not able to achieve this goal because
approximately 30% of patients refused follow-up angiography.
Whether we have committed a  error in this situation is unclear,
but my biostatistician tells me that performing a post hoc power
calculation on the basis of observed effects is pointless because it
has a 1:1 relationship with the P value. In other words, a clinical
study with negative findings will always result in a low post hoc
statistical power.
The differences between the 2 groups that you alluded to
became even less if patent, but stenotic vein grafts were also
included in our analysis. Furthermore, because we obtained, on
multivariable analysis, an OR of only 1.15, being very close to 1,
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large CI, we are reasonably sure of the reliability of our data.
In answer to your last question regarding what happened to
these patients, only one patient in the open group had angina 2
months after the operation. This patient underwent stenting of a
stenosed obtuse marginal graft, which subsequently occluded at 4
months. The rest of the patients who were found to have either
occlusion or stenotic grafts at the time of follow-up angiography
were asymptomatic. Of these patients, most were treated medi-
cally. Four underwent stenting of a stenotic graft, and 4 had
percutaneous catheter-based interventions to the native vessels.
Dr Vaughn Starnes (Los Angeles, Calif). Just a couple of
quick technical questions, Kwok, if you could. First, do you
heparinize your patients before beginning the endoscopic vein
harvesting?
Dr Yun. Yes.
Dr Starnes. What do you do if the segment looks burned but
does not leak? Do you resect that? We found that some of our
pulmonary arteries are excellent, with no burn on the vein. Occa-
sionally, we get a vein brought up, and it does not leak, but there
is obviously a burned area where there is a large branch where they
tried to bovie it off.
Dr Yun. In terms of the anticoagulation, initially, before this
study, we were concerned because sometimes we would see littleThe Journal of ThoraciSince that time, we have given about 5000 units of heparin before
the endoscopic instruments are introduced, and that is what we did
for this study.
In terms of burn marks, those are concerns, and we do try to
eliminate them as much as possible, especially at big branches,
where it looks like it is burned right down to the base.
Dr Thomas Burden (Stanford, Calif). Any flow-probe infor-
mation on any of these patients? Flow probes are being more
widely used by more of us as time goes by, especially if we are
using beating-heart technologies. Have any of these patients had
flow-probe analysis along with your angiography?
Dr Yun. Yes, all of them have flow-probe measurements, and
we found that the high flow-probe rate had an independent pro-
tective effect on vein graft closure.
Dr Burden. Do you know what that number is? Do you depict
that as greater than a 30-, 40-, 50-, or 70 mL flow?
Dr Yun. It was done in increments of 10 mL/min. I do not
know whether there was an exact cutoff point at which it became
significantly better.
Dr Burden. And there was no correlation between flow and
patency at 6 months?
Dr Yun. There was.
Dr Burden. There was?
Dr Yun. Yes, on multivariable analysis, the higher the flowstrands of fibrin in the vein, and that was what prompted our study. rate, the higher the patency rate.
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